Article By Greg Cima / January 11, 2024
In the immediate wake of the COVID-19 pandemic, there was initial enthusiasm that over-the-counter self-administered tests would see an upshot as some believed the widespread use of antigen-based COVID-19 tests would carry over to tests for other indication.
PR Newswire / June 16, 2025 SALT LAKE CITY, June 16, 2025 /PRNewswire/ — Averra Holdings, LLC (“Averra”), a portfolio company of Banner Capital, is pleased to announce a partnership with ZIEN Medical Technologies (“ZIEN”). Read More
Read MoreOutcome Capital Life Science Market Pulse May 2025 Click to view our LifeSciences Pulse Newsletter
DownloadWould you like to learn more about working with Outcome Capital or discuss your specific needs?